These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The fluorescent probe prodan characterizes the warfarin binding site on human serum albumin. Moreno F, Cortijo M, González-Jiménez J. Photochem Photobiol; 1999 Jan; 69(1):8-15. PubMed ID: 10063798 [Abstract] [Full Text] [Related]
24. Competition between serum albumin and soluble fraction of liver for binding of warfarin and other drugs. Wosilait WD, Ryan MP, Byington KH. Res Commun Chem Pathol Pharmacol; 1981 Apr; 32(1):113-21. PubMed ID: 7291718 [Abstract] [Full Text] [Related]
25. The lone tryptophan residue of human serum albumin as part of the specific warfarin binding site. Binding of dicoumarol to the warfarin, indole and benzodiazepine binding sites. Fehske KJ, Müller WE, Wollert U, Velden LM. Mol Pharmacol; 1979 Nov; 16(3):778-89. PubMed ID: 93690 [No Abstract] [Full Text] [Related]
26. Relations between high-affinity binding sites for L-tryptophan, diazepam, salicylate and Phenol Red on human serum albumin. Kragh-Hansen U. Biochem J; 1983 Jan 01; 209(1):135-42. PubMed ID: 6847607 [Abstract] [Full Text] [Related]
27. In vitro binding study of gemfibrozil to human serum proteins and erythrocytes: interactions with other drugs. Hamberger C, Barre J, Zini R, Taiclet A, Houin G, Tillement JP. Int J Clin Pharmacol Res; 1986 Jan 01; 6(6):441-9. PubMed ID: 3468088 [Abstract] [Full Text] [Related]
28. The effects of oleic acid, tolbutamide, and oxyphenbutazone on the binding of warfarin by human serum albumin. Wosilait WD, Ryan MP. Res Commun Chem Pathol Pharmacol; 1979 Sep 01; 25(3):577-84. PubMed ID: 504792 [Abstract] [Full Text] [Related]
33. Competition between diftalone and other drugs for the binding site(s) on human serum albumin. Assandri A, Perazzi A. Med Biol; 1976 Jun 01; 54(3):187-92. PubMed ID: 940363 [Abstract] [Full Text] [Related]
34. Differentiated effects of liver cirrhosis on the albumin binding sites for diazepam, salicylic acid and warfarin. Kober A, Jenner A, Sjöholm I. Biochem Pharmacol; 1978 Jun 01; 27(23):2729-35. PubMed ID: 728226 [No Abstract] [Full Text] [Related]
37. Quantitative contribution of endogenous compounds and hypoalbuminemia in reducing the binding of furosemide in the plasma of newborn infants. Viani A, Pacifici GM. Dev Pharmacol Ther; 1992 Jun 01; 18(1-2):39-43. PubMed ID: 1483361 [Abstract] [Full Text] [Related]
38. Dry polyacrylamide batch method for studying drug protein binding. Julkunen RJ, Himberg JJ. Arzneimittelforschung; 1976 Apr 01; 26(4):560-3. PubMed ID: 989013 [Abstract] [Full Text] [Related]